J.M. Jamison, J. Gilloteaux, L. Perlaky, M. Thiry, K. Smetana, D.R. Neal, K. McGuire, and J.L. Summers. "Nucleolar Changes and Fibrillarin Redistribution Following Apatone® Treatment of Human Bladder Carcinoma Cells." Journal of Histochemistry and Cytochemistry 58 (2010): 635-652.
J. Gilloteaux, J.M. Jamison, D.R. Neal, M. Loukas, T. Doberzstyn, and J.L. Summers. "Cell Damage and Death by Autoschizis in Human Bladder (RT4) Carcinoma Cells Resulting from Treatment by Ascorbate and Menadione." Ultrastructural Pathology 34 (2010): 140-160.
B. Tareen, J.L. Summers, J.M. Jamison, D.R. Neal, K. McGuire, L. Gerson, and A.A. Diokno. "12 Week, Open Label, Phase I/IIa Study Using Apatone® for the Treatment of Prostate Cancer Patients Who Have Failed Standard Therapy." International Journal of Medical Science 5 (2008): 62-67.
J. Gilloteaux, J.M. Jamison, D. Arnold, D.R. Neal, and J.L. Summers. "Morphology and DNA Degeneration During Autoschizic Cell Death in Bladder Carcinoma T24 Cells Induced by Ascorbate and Menadione Treatment." Anatomical Record Part A: Discoveries in Molecular, Cellular, and Evoluntionary Biology 288 (2006): 58-83.
J.M. Jamison, J. Gilloteaux, H.S. Taper, P. Buc Calderon, L. Perlaky, M. Thiry, D.R. Neal, J.L. Blank, R.J. Clements, and J.L. Summers. "The In Vitro and In Vivo Antitumor Activity of Vitamin C: K3 Combinations Against Prostate Cancer." Prostate Cancer. Lucas, J.L. Hauppauge, NY: Nova Science Publishers, Inc., 2005. 189-236.
Click here for a full list of publications of the Apatone Development Research